PEG–lipid–PLGA hybrid nanoparticles loaded with berberine–phospholipid complex to facilitate the oral delivery efficiency

References

• Anal AK, Stevens WF. (2005). Chitosan–alginate multilayer beads for controlled release of ampicillin. Int J Pharm 290:45–54
   PubMed Web of Science ®Google Scholar
• Chen D, Xia D, Li X, et al. (2013). Comparative study of Pluronic® F127-modified liposomes and chitosan-modified liposomes for mucus penetration and oral absorption of cyclosporine A in rats. Int J Pharm 449:1–9
   PubMed Web of Science ®Google Scholar
• Chen K, Li G, Geng F, et al. (2014). Berberine reduces ischemia/reperfusion-induced myocardial apoptosis via activating AMPK and PI3K–Akt signaling in diabetic rats. Apoptosis 19:946–57
   PubMed Web of Science ®Google Scholar
• Cheow WS, Hadinoto K. (2011). Factors affecting drug encapsulation and stability of lipid-polymer hybrid nanoparticles. Colloids Surf B Biointerfaces 85:214–20
   PubMed Web of Science ®Google Scholar
• Cu Y, Saltzman WM. (2009). Controlled surface modification with poly(ethylene)glycol enhances diffusion of PLGA nanoparticles in human cervical mucus. Mol Pharm 6:173–81
   PubMed Web of Science ®Google Scholar
• Cui F, Shi K, Zhang L, et al. (2006). Biodegradable nanoparticles loaded with insulin–phospholipid complex for oral delivery: preparation, in vitro characterization and in vivo evaluation. J Control Release 114:242–50
   PubMed Web of Science ®Google Scholar
• Dong S-F, Hong Y, Liu M, et al. (2011). Berberine attenuates cardiac dysfunction in hyperglycemic and hypercholesterolemic rats. Eur J Pharmacol 660:368–74
   PubMed Web of Science ®Google Scholar
• Ford Versypt AN, Pack DW, Braatz RD. (2013). Mathematical modeling of drug delivery from autocatalytically degradable PLGA microspheres – a review. J Control Release 165:29–37
   PubMed Web of Science ®Google Scholar
• Godugu C, Patel AR, Doddapaneni R, et al. (2014). Approaches to improve the oral bioavailability and effects of novel anticancer drugs berberine and betulinic acid. PloS One 9:e89919
   PubMed Web of Science ®Google Scholar
• Hadinoto K, Sundaresan A, Cheow WS. (2013). Lipid–polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review. Eur J Pharm Biopharm 85:427–43
   PubMed Web of Science ®Google Scholar
• Hou Z, Li Y, Huang Y, et al. (2012). Phytosomes loaded with mitomycin C–soybean phosphatidylcholine complex developed for drug delivery. Mol Pharm 10:90–101
   PubMed Web of Science ®Google Scholar
• Khalil NM, Nascimento TCFd, Casa DM, et al. (2013). Pharmacokinetics of curcumin-loaded PLGA and PLGA-PEG blend nanoparticles after oral administration in rats. Colloids Surf B Biointerfaces 101:353–60
   PubMed Web of Science ®Google Scholar
• Kong W, Wei J, Abidi P, et al. (2004). Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nat Med 10:1344–51
   PubMed Web of Science ®Google Scholar
• Liu C-S, Zheng Y-R, Zhang Y-F, et al. (2016). Research progress on berberine with a special focus on its oral bioavailability. Fitoterapia 109:274–82
   PubMed Web of Science ®Google Scholar
• Nekkanti V, Rueda J, Wang Z, et al. (2016). Comparative evaluation of proliposomes and self micro-emulsifying drug delivery system for improved oral bioavailability of nisoldipine. Int J Pharm 505:79–88
   PubMed Web of Science ®Google Scholar
• Nguyen TX, Huang L, Liu L, et al. (2014). Chitosan-coated nano-liposomes for the oral delivery of berberine hydrochloride. J Mater Chem B 2:7149–59
   PubMed Web of Science ®Google Scholar
• Park J-J, Seo S-M, Kim EJ, et al. (2012). Berberine inhibits human colon cancer cell migration via AMP-activated protein kinase-mediated downregulation of integrin β1 signaling. Biochem Biophys Res Commun 426:461–7
   PubMed Web of Science ®Google Scholar
• Pund S, Borade G, Rasve G. (2014). Improvement of anti-inflammatory and anti-angiogenic activity of berberine by novel rapid dissolving nanoemulsifying technique. Phytomedicine 21:307–14
   PubMed Web of Science ®Google Scholar
• Ricciardi R, Auriemma F, De Rosa C, et al. (2004). X-ray diffraction analysis of poly(vinyl alcohol) hydrogels, obtained by freezing and thawing techniques. Macromolecules 37:1921–7
   Web of Science ®Google Scholar
• Shakweh M, Besnard M, Nicolas V, et al. (2005). Poly (lactide-co-glycolide) particles of different physicochemical properties and their uptake by peyer's patches in mice. Eur J Pharm Biopharm 61:1–13
   PubMed Web of Science ®Google Scholar
• Sun B, Luo C, Li L, et al. (2016). Core-matched encapsulation of an oleate prodrug into nanostructured lipid carriers with high drug loading capability to facilitate the oral delivery of docetaxel. Colloids Surf B Biointerfaces 143:47–55
   PubMed Web of Science ®Google Scholar
• Wang Z, Chen Z, Yang S, et al. (2014). Berberine ameliorates collagen-induced arthritis in rats associated with anti-inflammatory and anti-angiogenic effects. Inflammation 37:1789–98
   PubMed Web of Science ®Google Scholar
• Xue M, Yang M, Zhang W, et al. (2013). Characterization, pharmacokinetics, and hypoglycemic effect of berberine loaded solid lipid nanoparticles. Int J Nanomed 8:4677–87
   PubMed Web of Science ®Google Scholar
• Yu F, Li Y, Chen Q, et al. (2016). Monodisperse microparticles loaded with the self-assembled berberine-phospholipid complex-based phytosomes for improving oral bioavailability and enhancing hypoglycemic efficiency. Eur J Pharm Biopharm 103:136–48
   PubMed Web of Science ®Google Scholar
• Yu F, Li Y, Liu CS, et al. (2015). Enteric-coated capsules filled with mono-disperse micro-particles containing PLGA-lipid-PEG nanoparticles for oral delivery of insulin. Int J Pharm 484:181–91
   PubMed Web of Science ®Google Scholar
• Zhang J, Li J, Ju Y, et al. (2015). Mechanism of enhanced oral absorption of morin by phospholipid complex based self-nanoemulsifying drug delivery system. Mol Pharm 12:504–13
   PubMed Web of Science ®Google Scholar
• Zhang Y, Cui Y-L, Gao L-N, et al. (2013). Effects of β-cyclodextrin on the intestinal absorption of berberine hydrochloride, a P-glycoprotein substrate. Int J Biol Macromol 59:363–71
   PubMed Web of Science ®Google Scholar